The model describing RPA exhaustion and ensuing replication catastrophe predicts that infliction of DNA replication stress over the RPA protection threshold either by cytotoxic chemotherapy or replication checkpoint inhibitors underlies the clinical response of cancer cells to the high levels of replication stress [196]. The gene discussed is RPA1; the disease is cancer.